Low CXCL11 expression is indicative of poor prognosis in rectal cancer patients undergoing preoperative chemoradiotherapy: a retrospective cohort study
CXCL11 expression may serve as an early predictor of clinical outcomes and aid in therapeutic decision-making by identifying individuals likely to respond to neoadjuvant chemoradiotherapy in rectal cancer.
Authors
- Ching‐Chieh Yang (ORCID: https://orcid.org/0000-0003-3823-4673)
- Hong-Yue Lai (ORCID: https://orcid.org/0000-0002-6197-9828)
- Sung-Wei Lee
- Yufeng Tian (ORCID: https://orcid.org/0000-0002-6814-7071)
- Yow‐Ling Shiue (ORCID: https://orcid.org/0000-0003-0798-5028)
- Wan‐Shan Li (ORCID: https://orcid.org/0000-0001-6679-4868)
- Cheng‐Yi Lin
- Hsin-Hwa Tsai
- Chia‐Lin Chou
Institutions
- Chung Hwa University of Medical Technology (TW)
- National Sun Yat-sen University (TW)
- China Medical University (TW)
- China Medical University Hospital (TW)
- Chi Mei Medical Center (TW)
- Chia Nan University of Pharmacy and Science (TW)
Publication Details
- Journal
- Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
- Published
- 2024-11-27
- DOI
- https://doi.org/10.1007/s00428-024-03974-7
- Citations
- 2
- Primary Topic
- Colorectal and Anal Carcinomas
- Type
- article
- Field-Weighted Citation Impact
- 1.15
Funders
- National Health Research Institutes
- China Medical University
- China Medical University, Taiwan
- National Science and Technology Council